Blank
Al-Azhar University – Gaza
2022
Turkish Journal of Pharmaceutical Sciences
Peroxisome Proliferator-Activated Receptors as Superior Targets for Treating Diabetic Disease, Design Strategies-Review Article
19
3
353
370
Turkish Pharmacists Association
Gazi University, Faculty of Pharmacy, Department of Pharmaceutical Chemistry, Ankara, Turkey; Al-Azhar University, Faculty of Pharmacy, Department of Pharmaceutical Chemistry and Pharmacognosy, Gaza Strip, Palestine
11
10.4274/tjps.galenos.2021.70105
2,4 thiazolidinedione derivative; antidiabetic agent; englitazone; fatty acid; heterodimer; high density lipoprotein; ligand; low density lipoprotein; netoglitazone; nonanoic acid; nuclear receptor coactivator; peroxisome proliferator activated receptor; pioglitazone; rosiglitazone; troglitazone; adverse event; adverse outcome; antidiabetic activity; cell proliferation; diabetes mellitus; drug design; drug sensitivity; glucose homeostasis; glycemic control; human; hyperglycemia; inflammation; insulin sensitivity; lipid homeostasis; monotherapy; non insulin dependent diabetes mellitus; ossification; pharmacokinetics; prevalence; Review; structure activity relation